Putting patients at the heart of clinical trials

Written by Trishna Bharadia

‘Patient-centric’ trials have been a hot topic for several years, with a big emphasis on trial design. It is well known that putting patients at the heart of the clinical trials process can improve recruitment and retention rates [1], which is much needed considering that 85% of all clinical trials fail to recruit sufficient patients and 80% are delayed because of recruitment delays and high dropout rates [2]. Most recently, the COVID-19 pandemic has shone a light on the importance of diverse representation in clinical trials to make them more patient centric. The US FDA and the Pharmaceutical Research and...

To view this content, please register now for access

It's completely free